A Randomized Trial of Deep Neuromuscular Blockade Reversed With Sugammadex Versus Moderate Neuromuscular Block Reversed With Neostigmine, on Postoperative Quality of Recovery

Trial Profile

A Randomized Trial of Deep Neuromuscular Blockade Reversed With Sugammadex Versus Moderate Neuromuscular Block Reversed With Neostigmine, on Postoperative Quality of Recovery

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Jun 2017

At a glance

  • Drugs Neostigmine (Primary) ; Sugammadex (Primary)
  • Indications Neuromuscular blockade
  • Focus Therapeutic Use
  • Acronyms DEEPBLOCK
  • Most Recent Events

    • 17 Jun 2017 Status changed from not yet recruiting to recruiting.
    • 26 May 2017 Planned initiation date changed from 30 Mar 2017 to 3 Jun 2017.
    • 03 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top